Latest Krensavage Asset Management, LLC Stock Portfolio
Krensavage Asset Management, LLC Performance:
2025 Q3: 20.38%YTD: 31.99%2024: 4.72%
Performance for 2025 Q3 is 20.38%, and YTD is 31.99%, and 2024 is 4.72%.
About Krensavage Asset Management, LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Krensavage Asset Management, LLC reported an equity portfolio of $234.7 Millions as of 30 Sep, 2025.
The top stock holdings of Krensavage Asset Management, LLC are UTHR, ENTA, JAZZ. The fund has invested 17.4% of it's portfolio in UNITED THERAPEUTICS CORP and 10.8% of portfolio in ENANTA PHARMACEUTICALS INC.
The fund managers got completely rid off JOHNSON & JOHNSON (JNJ) stocks. They significantly reduced their stock positions in INDIVIOR PLC, CARDINAL HEALTH INC (CAH) and SUPERNUS PHARMACEUTICALS INC (SUPN). Krensavage Asset Management, LLC opened new stock positions in BIOMARIN PHARMACEUTICAL INC (BMRN), BIOGEN INC (BIIB) and EVOLUS INC (EOLS). The fund showed a lot of confidence in some stocks as they added substantially to SANOFI-ADR, VANDA PHARMACEUTICALS INC (VNDA) and EXELIXIS INC (EXEL).
The top stock holdings of Krensavage Asset Management, LLC are UTHR, ENTA, JAZZ. The fund has invested 17.4% of it's portfolio in UNITED THERAPEUTICS CORP and 10.8% of portfolio in ENANTA PHARMACEUTICALS INC.
The fund managers got completely rid off JOHNSON & JOHNSON (JNJ) stocks. They significantly reduced their stock positions in INDIVIOR PLC, CARDINAL HEALTH INC (CAH) and SUPERNUS PHARMACEUTICALS INC (SUPN). Krensavage Asset Management, LLC opened new stock positions in BIOMARIN PHARMACEUTICAL INC (BMRN), BIOGEN INC (BIIB) and EVOLUS INC (EOLS). The fund showed a lot of confidence in some stocks as they added substantially to SANOFI-ADR, VANDA PHARMACEUTICALS INC (VNDA) and EXELIXIS INC (EXEL).
Krensavage Asset Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Krensavage Asset Management, LLC made a return of 20.38% in the last quarter. In trailing 12 months, it's portfolio return was 27.32%.
New Buys
| Ticker | $ Bought |
|---|---|
| biomarin pharmaceutical inc | 21,959,000 |
| biogen inc | 1,401,000 |
| evolus inc | 614,000 |
New stocks bought by Krensavage Asset Management, LLC
Additions
| Ticker | % Inc. |
|---|---|
| sanofi-adr | 117 |
| vanda pharmaceuticals inc | 15.17 |
| biontech se-adr | 8.15 |
| exelixis inc | 5.07 |
| jazz pharmaceuticals plc | 1.82 |
Additions to existing portfolio by Krensavage Asset Management, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| indivior plc | -65.16 |
| cardinal health inc | -44.86 |
| supernus pharmaceuticals inc | -23.05 |
| united therapeutics corp | -3.46 |
| avadel pharmaceuticals | -0.31 |
Krensavage Asset Management, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| johnson & johnson | -6,110,000 |
Krensavage Asset Management, LLC got rid off the above stocks
Sector Distribution
Krensavage Asset Management, LLC has about 75.4% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 75.4 |
| Others | 24.6 |
Market Cap. Distribution
Krensavage Asset Management, LLC has about 33.3% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 33.3 |
| UNALLOCATED | 24.6 |
| MID-CAP | 21.2 |
| MICRO-CAP | 10.8 |
| SMALL-CAP | 10.2 |
Stocks belong to which Index?
About 30.1% of the stocks held by Krensavage Asset Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 69.9 |
| RUSSELL 2000 | 23.6 |
| S&P 500 | 6.5 |
Krensavage Asset Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Krensavage Asset Management, LLC
Krensavage Asset Management, LLC has 17 stocks in it's portfolio. About 86.2% of the portfolio is in top 10 stocks. EXEL proved to be the most loss making stock for the portfolio. UTHR was the most profitable stock for Krensavage Asset Management, LLC last quarter.
Last Reported on: 17 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ALKS | alkermes plc | 2.66 | 207,822 | 6,235,000 | unchanged | 0.00 | ||
| BIIB | biogen inc | 0.60 | 10,000 | 1,401,000 | new | |||
| BMRN | biomarin pharmaceutical inc | 9.36 | 405,450 | 21,959,000 | new | |||
| CAH | cardinal health inc | 4.93 | 73,745 | 11,575,000 | reduced | -44.86 | ||
| ENTA | enanta pharmaceuticals inc | 10.78 | 2,114,440 | 25,310,000 | unchanged | 0.00 | ||
| EOLS | evolus inc | 0.26 | 100,000 | 614,000 | new | |||
| EXEL | exelixis inc | 9.12 | 518,526 | 21,415,000 | added | 5.07 | ||
| JAZZ | jazz pharmaceuticals plc | 9.42 | 167,816 | 22,118,000 | added | 1.82 | ||
| JNJ | johnson & johnson | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| REGN | regeneron pharmaceuticals | 0.96 | 4,000 | 2,249,000 | unchanged | 0.00 | ||
| SUPN | supernus pharmaceuticals inc | 7.40 | 363,479 | 17,371,000 | reduced | -23.05 | ||
| UTHR | united therapeutics corp | 17.44 | 97,646 | 40,934,000 | reduced | -3.46 | ||
| VNDA | vanda pharmaceuticals inc | 2.51 | 1,180,390 | 5,890,000 | added | 15.17 | ||
| sanofi-adr | 6.52 | 323,946 | 15,290,000 | added | 117 | |||
| avadel pharmaceuticals | 6.22 | 955,860 | 14,596,000 | reduced | -0.31 | |||
| gsk plc-spon adr | 5.00 | 271,729 | 11,728,000 | unchanged | 0.00 | |||
| indivior plc | 3.49 | 339,532 | 8,186,000 | reduced | -65.16 | |||
| biontech se-adr | 3.34 | 79,366 | 7,827,000 | added | 8.15 | |||